Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS buprenorphine practice guidelines /

Bibliographic Details
Corporate Author: United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation (Author)
Format: Government Document eBook
Language:English
Published: [Washington, D.C.] : U.S. Department of Health and Human Services, 2022.
Subjects:
Online Access:https://purl.fdlp.gov/GPO/gpo213242

Similar Items